Physician profile
Mitchell T Jones
NPI 1952329385
$6,472.76
in general payments reported to CMS, 2019-2025
38 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,758 · 2020: $527 · 2021: $892 · 2022: $989 · 2023: $641 · 2024: $663 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,306.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $776.86 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $719.96 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $712.11 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $619.66 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $547.87 | 2019-2025 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $504.08 | 2019-2025 | |
| Glaxosmithkline, LLC. | $259.24 | 2019-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Abiomed | $252.49 | 2019-2024 | Impella |
| Shockwave Medical, INC | $241.67 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.74 | 2019-2025 | Jardiance |
| Medtronic, INC. | $200.91 | 2021-2025 | Linq II, Micra, Complete Se Vascular |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.22 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $125.00 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biosense Webster, INC. | $125.00 | 2022 | |
| Cvrx, INC. | $102.03 | 2021-2024 | Barostim Neo System |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $91.70 | 2019-2025 | |
| Esperion Therapeutics, INC. | $81.53 | 2020-2021 | |
| Amarin Pharma, INC. | $69.89 | 2019-2020 | |
| Baxter Healthcare | $69.11 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $62.80 | 2021-2025 | |
| Philips North America LLC | $53.96 | 2024-2025 | Extended Holter, (5091) Amb Mon & Diag Und |
| Alnylam Pharmaceuticals INC. | $53.10 | 2020-2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $48.12 | 2023 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $43.07 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $40.30 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $37.33 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.68 | 2021 | |
| Novo Nordisk INC | $24.43 | 2024 | Rybelsus, Ozempic |
| Abbott Laboratories | $21.23 | 2021 | |
| Avinger INC. | $21.17 | 2022 | |
| Inspire Medical Systems, INC. | $21.03 | 2025 | Inspire |
| Daiichi Sankyo INC. | $19.28 | 2023 | Injectafer |
| Irhythm Technologies, INC. | $16.69 | 2024 | Zio Monitor, Zio Xt Patch |
| Convatec INC. | $15.53 | 2025 | |
| Arbor Pharmaceuticals, INC. | $14.88 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $14.01 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.74 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.